This really puts Mesoblast on the map. It’s the perfect time for a big pharma to partner up, Msb has done the hard yards it’s at the sweet point for a BP to jump in at a low risk to either run another trial or confirmatory trial prior to approval and hitting the market . I can’t see the FDA giving accelerated approval especially missing the main (minor) endpoint of hospital visits, I understand the argument to that being we hit a home run on secondary (major) endpoints but as we’ve seen with the fda they’re.. “hard to please” . I can see them saying “good results, now prove it with a well conducted smaller trial focusing on the right patients and MACE reduction which is still a great outcome. Again the hard work is done Mesoblast have all their data and a better understanding of their cells a narrowed down specific trial should be a hell of a lot easier to design (hopefully with a BP by their side) good luck everyone
- Forums
- ASX - By Stock
- MSB
- Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes, page-211
-
-
- There are more pages in this discussion • 796 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9996 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 18069 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9996 | 0.990 |
2 | 32880 | 0.985 |
4 | 71034 | 0.980 |
2 | 3059 | 0.975 |
7 | 145890 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 1132 | 1 |
1.000 | 9500 | 3 |
1.005 | 35000 | 1 |
1.010 | 58113 | 4 |
1.015 | 46100 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online